Edirol (eldecalcitol) / Taisho, Roche 
Welcome,         Profile    Billing    Logout  

8 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Edirol (eldecalcitol) / Roche, Taisho
ELEGANT, NCT06385093: A Study on the Prevention and Treatment of GIOP With Eldecalcitol

Not yet recruiting
4
314
RoW
Eldecalcitol capsules, Edirol, Alfacalcidol tablets, Calcium carbonate tablets
Chinese SLE Treatment And Research Group, Beijing Life oasis public service center
Rheumatoid Arthritis, Osteoporosis, Osteopenia
12/25
03/26
ChiCTR2200066283: Efficacy and ADR monitoring of Eldecalcitol in the treatment of postmenopausal and diabetic osteoporosis

Not yet recruiting
4
50
 
N/A ;N/A
The Seventh Affiliated Hospital of Sun Yat-Sen University; The Seventh Affiliated Hospital of Sun Yat-Sen University, Three engineering projects in Department of Endocrinology
Osteoporosis
 
 
NCT05884372: Comparison of Efficacy of Denosumab With Eldecalcitol or Native Vitamin D in Postmenopausal Women With Osteoporosis.

Recruiting
4
100
RoW
Eldecalcitol, Native Vitamin D, Denosumab, Calcium
Xi'an Honghui Hospital, Chugai Pharma China Co., Ltd.
Osteoporosis in Postmenopausal Women
12/24
06/25
ChiCTR2300070456: Comparison of the efficacy and safety between eldecalcitol and calcitriol in postmenopausal women with low bone mineral density and mild osteoporosis

Not yet recruiting
4
300
 
Orally 0.75 μg qd Eldecalcitol ;Orally 0.5 μg qd Calcitriol
Shanghai Sixth People's Hospital; Shanghai Sixth People's Hospital, Chugai Pharma
Osteoporosis
 
 
EFFECT, NCT05902078: Eldecalcitol and Calcitriol in Postmenopausal Women With Low Bone Mineral Density or Mild Osteoporosis

Recruiting
4
300
RoW
Eldecalcitol capsules, Edirol, Calcitriol capsules, Haidewei
Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Chugai Pharma China Co., Ltd.
Low Bone Mineral Density, Postmenopausal Osteoporosis
06/25
12/25
NCT03755193: Examination of Efficacy and Safety of Other Anti-Resorption Drugs After 2-year-Denosumab Therapy in Japanese Osteoporosis Patients

Recruiting
2
90
Japan
SERM "Viviant®Tablet 20mg" and ELD "Edirol®Tablet 0.75ug", Bisphosphonates and ELD "Edirol®Tablet 0.75ug", ELD "Edirol®Tablet 0.75ug"
Shinshu University
Osteoporosis
11/24
11/26
NCT02306187: The Effectiveness of Eldecalcitol in the Bisphosphonate Non-respondered-patients With Osteoporosis

Recruiting
1
100
Japan
Edirol, Eldecalcitol
Shinshu University
Osteoporosis
12/22
12/24
NCT05433207: Post-Marketing Drug Intensive Monitoring Surveillance of EDIROL in Patients With Postmenopausal Osteoporosis

Not yet recruiting
N/A
1000
RoW
Eldecalcitol soft capsules
Chugai Pharmaceutical
Postmenopausal Osteoporosis
01/25
01/25

Download Options